IL117455A0 - Piperidine derivatives process for the preparation thereof and application thereof in therapeutics - Google Patents

Piperidine derivatives process for the preparation thereof and application thereof in therapeutics

Info

Publication number
IL117455A0
IL117455A0 IL11745596A IL11745596A IL117455A0 IL 117455 A0 IL117455 A0 IL 117455A0 IL 11745596 A IL11745596 A IL 11745596A IL 11745596 A IL11745596 A IL 11745596A IL 117455 A0 IL117455 A0 IL 117455A0
Authority
IL
Israel
Prior art keywords
therapeutics
preparation
application
piperidine derivatives
derivatives process
Prior art date
Application number
IL11745596A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL117455A0 publication Critical patent/IL117455A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11745596A 1995-03-13 1996-03-12 Piperidine derivatives process for the preparation thereof and application thereof in therapeutics IL117455A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502863A FR2731708B1 (fr) 1995-03-13 1995-03-13 Derives de piperidine, leur procede de preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
IL117455A0 true IL117455A0 (en) 1996-07-23

Family

ID=9476960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11745596A IL117455A0 (en) 1995-03-13 1996-03-12 Piperidine derivatives process for the preparation thereof and application thereof in therapeutics

Country Status (15)

Country Link
EP (1) EP0732334A1 (xx)
JP (1) JPH08269058A (xx)
KR (1) KR960034205A (xx)
CN (1) CN1140174A (xx)
AU (1) AU4800896A (xx)
CA (1) CA2171579A1 (xx)
CZ (1) CZ75496A3 (xx)
FR (1) FR2731708B1 (xx)
HU (1) HUP9600624A2 (xx)
IL (1) IL117455A0 (xx)
NO (1) NO961000L (xx)
NZ (1) NZ286164A (xx)
PL (1) PL313204A1 (xx)
SK (1) SK34196A3 (xx)
ZA (1) ZA961994B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69625819T2 (de) * 1995-09-18 2003-11-06 Glaxo Group Ltd Die verwendung von ondansetron zur herstellung eines medikamentes zur behandlung von tremor
TW527186B (en) 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators
FR2801589A1 (fr) * 1999-11-25 2001-06-01 Sanofi Synthelabo Derives de 2-arylquinoleine, leur preparation et leur application en therapeutique
FR2816619B1 (fr) * 2000-11-15 2003-01-31 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
PL365080A1 (en) * 2000-08-08 2004-12-27 Sanofi-Aventis Benzimidazole derivatives, preparation and therapeutic use thereof
FR2816941B1 (fr) * 2000-11-23 2003-01-31 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2816942B1 (fr) * 2000-11-23 2003-05-09 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
WO2014143768A1 (en) * 2013-03-15 2014-09-18 Incyte Corporation Tricyclic heterocycles as bet protein inhibitors
CA2917319A1 (en) 2013-07-08 2015-01-15 Incyte Holdings Corporation Tricyclic heterocycles as bet protein inhibitors
WO2015081189A1 (en) 2013-11-26 2015-06-04 Incyte Corporation Bicyclic heterocycles as bet protein inhibitors
US9399640B2 (en) 2013-11-26 2016-07-26 Incyte Corporation Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
US9309246B2 (en) 2013-12-19 2016-04-12 Incyte Corporation Tricyclic heterocycles as BET protein inhibitors
BR112016024626B1 (pt) 2014-04-23 2023-03-21 Incyte Holdings Corporation Compostos 1h-pirrolo[2,3-c]piridin-7(6h)-onas e pirazolo[3,4-c]piridin-7 (6h)-onas, uso dos mesmos, composição farmacêutica que os compreende e método de inibição de uma proteína bet
EP3194406B8 (en) * 2014-09-15 2021-03-31 Incyte Corporation Tricyclic heterocycles for use as bet protein inhibitors
TW201722966A (zh) 2015-10-29 2017-07-01 英塞特公司 Bet蛋白質抑制劑之非晶固體形式
PE20190623A1 (es) 2016-06-20 2019-04-26 Incyte Corp Formas solidas cristalinas de un inhibidor de bet
JP2021530442A (ja) * 2018-06-28 2021-11-11 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co., Ltd. 縮合三環系複素環化合物およびその治療上の使用
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
FR2696176B1 (fr) * 1992-09-28 1994-11-10 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FR2710915B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
NZ286164A (en) 1996-11-26
KR960034205A (ko) 1996-10-22
FR2731708B1 (fr) 1997-04-30
AU4800896A (en) 1996-09-26
HU9600624D0 (en) 1996-05-28
PL313204A1 (en) 1996-09-16
NO961000L (no) 1996-09-16
CN1140174A (zh) 1997-01-15
EP0732334A1 (fr) 1996-09-18
SK34196A3 (en) 1996-10-02
HUP9600624A2 (en) 1997-01-28
CZ75496A3 (en) 1996-10-16
JPH08269058A (ja) 1996-10-15
FR2731708A1 (fr) 1996-09-20
CA2171579A1 (en) 1996-09-14
NO961000D0 (no) 1996-03-12
ZA961994B (en) 1996-09-03

Similar Documents

Publication Publication Date Title
IL107132A0 (en) Piperidine derivatives,their preparation and their application in therapeutics
ZA961994B (en) Piperidine derivatives process for the preparation thereof and application thereof in therapeutics
IL111148A0 (en) Imidazol-4- ylpiperidine derivatives, their preparation and their application in therapeutics
ZA964138B (en) Substituted camptothecin derivatives and process for their preparation
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
ZA981976B (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
ZA943649B (en) Piperidine derivatives their preparation and use
HU9502244D0 (en) 3-substituted 5-quinolinecarboxylicacid-derivative and process for its preparation
SG44059A1 (en) Process for preparing acetoxyazetidinone derivative and intermediate thereof
AUPN002694A0 (en) Improvements in and relating to hangers for garments
GB2306985B (en) Improvements in milling
ZA985727B (en) (1H-imidazol-4-YL) piperidine derivatives their preparation and their application in therapeutics
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
ZA967558B (en) Alpha-phenylpiperidine-1-propanol derivatives their preparation and their application in therapeutics
GB2299595B (en) Improvements in firrings for conservatories
GB9513979D0 (en) Improvements in or relating to supports for partitions and the like
AU7423196A (en) Improvements in cots
HUP9601520A3 (en) Substituted quinoline-intermediates and process for preparation the same
HUP9601521A2 (en) Substituted quinoline-intermediates and process for preparation the same
HU9500156D0 (en) Pharmaceutical composition and process
GB9408708D0 (en) Dihydrophenanthrenone derivatives and process for their preparation
ZA95248B (en) Anti-fungal methods and materials
KR0159645B1 (en) Process for the preparation of poly--hydroxybutyrate-(o-ñô-hydroxyvalerate)and strain for using in said process